Chloride channel protein ClC-Kb (CLCNKB)

Chloride channel protein ClC-Kb (encoded by the CLCNKB gene) is a voltage-gated chloride channel primarily expressed in the kidney, particularly in the nephron segments including the thick ascending limb of Henle's loop, the distal convoluted tubule, and the collecting duct[1][6][7]. As part of the CLC family of ion channels, ClC-Kb mediates the selective transport of chloride ions across the plasma membrane, playing a central role in renal chloride reabsorption and maintenance of salt and water balance[1][4][6][7]. Dysfunction or mutations in CLCNKB cause Bartter syndrome type III, an autosomal recessive disorder characterized by salt wasting, hypokalemia, metabolic alkalosis, and normal or low blood pressure[1][2][4]. ClC-Kb is also a potential therapeutic target for modulating blood pressure and renal electrolyte handling[3]. The protein requires the accessory beta subunit barttin for its functionality in vivo, and structural studies show a high degree of similarity to other ClC family members, with a dimeric architecture and complex regulation by pH, calcium, and interactions with other proteins[3][4]. No widely used, clinically approved drugs directly target ClC-Kb, but experimental modulators continue to be developed and assessed for therapeutic potential[3].

Other names

ClC-KbCLCNKBClC-K2CLCKBhClC-Kbchloride channel Kbchloride voltage-gated channel Kbchloride channel protein ClC-Kbchloride channel, kidney, Bchloride channel, voltage-sensitive Kb

Channel blockers/inhibitors: Compounds that inhibit the channel reduce chloride permeation and affect electrolyte homeostasis